T1	Participants 78 199	children with standard-risk acute lymphoblastic leukemia: report of the Children's Oncology Group CCG-1952 clinical trial
T2	Participants 206 245	Children's Cancer Group 1952 (CCG-1952)
T3	Participants 478 518	After remission induction, 2027 patients
T4	Participants 1317 1321	boys
